The global healthcare data monetization market is expected to grow from one dollar to two billion dollars the next five years. There are a lot of use cases for healthcare data with life sciences companies, medtech companies, payers naturally, but also increasingly with AI and deep tech companies that require very large data sets to train their algorithms and develop new products. The amount of available healthcare data continues to increase. It is estimated today that the market will grow from two thousand exabytes of data in twenty twenty all the way up to fifteen thousand exabytes by twenty twenty five, with about thirty percent of the global data being actually healthcare data today.
This creates significant opportunities for this emerging market to grow, considering on the one side the demand from life sciences, medtech and technology companies, on the other hand the supply side with healthcare providers, pathology operators being the custodian of this data. And this market is progressively creating, taking form by region by country, creating a lot of opportunities for healthcare providers to actually add new revenue streams to their business. However, healthcare data is not as available in the Asia Pacific region as it is in the West, in Europe and the US in particular, making it even more valuable for the end users.
The value of patient data can vary significantly by time, from a couple of dozen dollars for typical EHR EMR EMR data all the way to several thousands for genomics or oncology patient records. The price of healthcare data can also vary significantly depending on the quality of the data, its longevity, the specialty you're looking at, but also the value added services that the data provider can provide to the end user. Overall, we see healthcare data monetization as a great opportunity for healthcare providers, in particular in the Asia Pacific and Middle Eastern regions, to add a new revenue stream to their business, is usually very profitable.
